GGrantIndex
← Leaderboards

Katharine S Ullman

University Of Utah

$6,899,000
Attributed
$8,586,625
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $727.8K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,586,625 · 4

By mechanism

R01$8,235,003 · 3
R21$351,622 · 1

Top collaborators

Most similar at University Of Utah

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsProteinsEventMembraneMitosisCell DivisionMitoticStructurePlayMolecularComplexDaughter CellChromosomesNuclear PorePathway InteractionsNuclearCell NucleusMalignant NeoplasmsRecruitGenomic InstabilityInsightDna DamageResponseExperimental Study

Grant awards (30)

ESCRT and MIT Complexes in Cytokinesis$364,826
R01 · FY2025 · GM
Dynamic Events at the Nuclear Envelope during Mitosis and Interphase$356,895
R01 · FY2025 · GM · contact PI
ESCRT and MIT Complexes in Cytokinesis$364,826
R01 · FY2024 · GM
Dynamic Events at the Nuclear Envelope during Mitosis and Interphase$356,895
R01 · FY2024 · GM · contact PI
ESCRT and MIT Complexes in Cytokinesis$364,826
R01 · FY2023 · GM
ESCRT and MIT Complexes in Cytokinesis$350,750
R01 · FY2022 · GM
Cellular Events Downstream of Mitotic Errors$343,125
R01 · FY2022 · GM · contact PI
ESCRT and MIT Complexes in Cytokinesis$33,960
R01 · FY2022 · GM
ESCRT and MIT Complexes in Cytokinesis$350,750
R01 · FY2021 · GM
Cellular Events Downstream of Mitotic Errors$343,125
R01 · FY2021 · GM · contact PI
ESCRT and MIT Complexes in Cytokinesis$350,750
R01 · FY2020 · GM
Cellular Events Downstream of Mitotic Errors$343,125
R01 · FY2020 · GM · contact PI
ESCRT and MIT Complexes in Cytokinesis$350,750
R01 · FY2019 · GM
Cellular Events Downstream of Mitotic Errors$343,125
R01 · FY2019 · GM · contact PI
Capitalizing on a New Biomarker Signature for Cancer Prognosis$157,177
R21 · FY2014 · CA · contact PI
Capitalizing on a New Biomarker Signature for Cancer Prognosis$194,445
R21 · FY2013 · CA · contact PI
The Nuclear Pore Complex: Interphase and Mitotic Function$310,509
R01 · FY2012 · GM · contact PI
The Nuclear Pore Complex: Interphase and Mitotic Function$310,509
R01 · FY2011 · GM · contact PI
The Nuclear Pore Complex: Interphase and Mitotic Function$315,796
R01 · FY2010 · GM · contact PI
The Nuclear Pore Complex: Interphase and Mitotic Function$309,093
R01 · FY2009 · GM · contact PI
The Nuclear Pore Complex: Interphase and Mitotic Function$269,331
R01 · FY2008 · GM · contact PI
The Nuclear Pore Complex: Interphase and Mitotic Function$269,331
R01 · FY2007 · GM · contact PI
The Nuclear Pore Complex: Interphase and Mitotic Function$277,375
R01 · FY2006 · GM · contact PI
The Nuclear Pore Complex: Interphase and Mitotic Function$284,050
R01 · FY2005 · GM
The Nuclear Pore Complex: Interphase and Mitotic Function$6,500
R01 · FY2005 · GM
MOLECULAR MECHANISMS OF NUCLEAR EXPORT$253,125
R01 · FY2004 · GM
MOLECULAR MECHANISMS OF NUCLEAR EXPORT$253,125
R01 · FY2003 · GM
MOLECULAR MECHANISMS OF NUCLEAR EXPORT$253,125
R01 · FY2002 · GM
MOLECULAR MECHANISMS OF NUCLEAR EXPORT$253,125
R01 · FY2001 · GM
MOLECULAR MECHANISMS OF NUCLEAR EXPORT$252,281
R01 · FY2000 · GM